OneSource Specialty Pharma Limited (ONESOURCE) Stock Statistics & Valuation Metrics

OneSource Specialty Pharma Limited has a market cap or net worth of ₹193.45B. The enterprise value is ₹199.46B.

OneSource Specialty Pharma Limited has 114,645,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

OneSource Specialty Pharma Limited’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -146.99%.

The current PE Ratio of OneSource Specialty Pharma Limited is ―. OneSource Specialty Pharma Limited’s PEG ratio is -0.00680.

In the last 12 months, OneSource Specialty Pharma Limited had revenue of 14.45B and earned -2.10M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -399.21M and capital expenditures -3.29B, giving a free cash flow of -3.69B billion.

OneSource Specialty Pharma Limited pays an annual dividend of ―, resulting in a dividend yield of ―

OneSource Specialty Pharma Limited upcoming earnings date is Aug 10, 2026, Before Open (Confirmed).

OneSource Specialty Pharma Limited as a current ratio of 83.44, with Debt / Equity ratio of 25.79%

In the past 12 months, OneSource Specialty Pharma Limited has paid -497.85M in taxes.

OneSource Specialty Pharma Limited EV to EBITDA ratio is 52.01, with an EV/FCF ratio of -95.78.

OneSource Specialty Pharma Limited has ₹1.80B in cash and marketable securities with ₹12.95B in debt, giving a net cash position of -₹11.15B billion.

Gross margin is 49.67%, with operating margin of 13.18%, and net profit margin of -0.01%.

The average price target for OneSource Specialty Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―